United States - English - NLM (National Library of Medicine)

vedco inc. - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane 1 ml in 1 ml - sevosol is indicated for induction and maintenance of general anesthesia in dogs. sevosol is contraindicated in dogs with a known sensitivity to sevoflurane or other halogenated agents.

United States - English - NLM (National Library of Medicine)

mwi veterinary supply co - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane 1 ml in 1 ml - flurovesstm is indicated for induction and maintenance of general anesthesia in dogs. flurovesstm is contraindicated in dogs with a known sensitivity to sevoflurane or other halogenated agents.

United States - English - NLM (National Library of Medicine)

zoetis inc. - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane 1 ml in 1 ml - sevoflo is indicated for induction and maintenance of general anesthesia in dogs. sevoflo is contraindicated in dogs with a known sensitivity to sevoflurane or other halogenated agents.

United States - English - NLM (National Library of Medicine)

abbvie inc. - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane 250 ml in 250 ml - ultane is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery. ultane should be administered only by persons trained in the administration of general anesthesia. facilities for maintenance of a patent airway, artificial ventilation, oxygen enrichment, and circulatory resuscitation must be immediately available. since level of anesthesia may be altered rapidly, only vaporizers producing predictable concentrations of sevoflurane should be used. - known or suspected genetic susceptibility to malignant hyperthermia (see warnings - malignant hyperthermia , clinical pharmacology - pharmacogenomics ). - known or suspected sensitivity to sevoflurane or to other halogenated inhalational anesthetics.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - sevoflurane 100% - volatile liquid for inhalation - 100 % - active: sevoflurane 100% - sevoflurane is indicated for induction and maintenance of general anaesthesia in adult and paediatric patients undergoing surgery.

New Zealand - English - Medsafe (Medicines Safety Authority)

device technologies new zealand - sevoflurane 100%{vol} - volatile liquid for inhalation - 100% v/v - active: sevoflurane 100%{vol} - piramal sevoflurane may be used for the induction and maintenance of general anaesthesia in adult and paediatric patients undergoing surgery.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - sevoflurane - inhalation vapour - 1ml/1ml

Canada - English - Health Canada

piramal critical care inc - sevoflurane - liquid - 99.97% - sevoflurane 99.97% - inhalation anesthetics

United States - English - NLM (National Library of Medicine)

piramal critical care inc - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane 1 ml in 1 ml - sojourn ® (sevoflurane, usp) is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery. sojourn ® (sevoflurane, usp) should be administered only by persons trained in the administration of general anesthesia. facilities for maintenance of a patent airway, artificial ventilation, oxygen enrichment, and circulatory resuscitation must be immediately available. since level of anesthesia may be altered rapidly, only vaporizers producing predictable concentrations of sevoflurane, usp should be used. • known or suspected genetic susceptibility to malignant hyperthermia. (see warnings - malignant hyperthermia,clinical pharmacology - pharmacogenomics ). • known or suspected sensitivity to sevoflurane or to other halogenated inhalational anesthetics.

Ireland - English - HPRA (Health Products Regulatory Authority)

piramal healthcare uk limited - sevoflurane - inhalation vapour liquid - 100 %v/v - halogenated hydrocarbons